Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc.AVAH · Entity 4246 | Chief Nursing Officer | February 14, 2023 | February 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aveanna Healthcare Holdings, Inc.
Report date February 14, 2023 · Filed February 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 199,893 |
Reported balance
After 2023-02-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-14 · Grant · Acquired 70,313 · Balance 199,893 F1: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting. F2: Includes (i) 369 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 1,439 shares acquired under the ESPP on July 8, 2022, and (iii) 4,874 shares acquired under the ESPP on January 5, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.
F2: Includes (i) 369 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 1,439 shares acquired under the ESPP on July 8, 2022, and (iii) 4,874 shares acquired under the ESPP on January 5, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2023 Filed Feb 17, 2023 01:57 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 70,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005333 · doc4.xml · nonDerivative · entry 1 Rubio Beth · CIK 0001858838 · Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,893 F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting. F2 · balance_after: Includes (i) 369 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 1,439 shares acquired under the ESPP on July 8, 2022, and (iii) 4,874 shares acquired under the ESPP on January 5, 2023. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 02:30 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 22,819 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006706 · doc4.xml · nonDerivative · entry 1 Rubio Beth · CIK 0001858838 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,898 F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:15 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000128 · doc4.xml · nonDerivative · entry 1 Rubio Beth · CIK 0001858838 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,079 F1 · price: Grant of stock-settled restricted stock unit, subject to four-year cliff vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.